Abstract: Compositions and methods are related to utilizing glycine and N-acetylcysteine for a variety of medical conditions related to reduced levels of glycine, N-acetylcysteine, and/or glutathione, for example, muscle loss such as sarcopenia, HIV infection and other infections, organ damage such as those from diabetes and insulin resistance and diabetic nephropathy, cardiac function and failure such as preventing or improving heart failure, fatty liver, cancer prevention, and other conditions.
Type:
Grant
Filed:
February 12, 2021
Date of Patent:
August 22, 2023
Assignees:
Baylor College of Medicine, Societe de Produits Nestle S.A.
Inventors:
Stephen Kirnon, Eric Freedland, Rajagopal V. Sekhar